NICE has rejected a new blood cancer drug, Yescarta, which is for the treatment of non-Hodgkin lymphoma, for NHS use due to the drug being too expensive.
from Daily Express :: Health Feed http://bit.ly/2PdMoza
via Buy Breast Actives
from Tumblr http://bit.ly/2MXkv0R
No comments:
Post a Comment